Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EBIT (2020 - 2025)

Historic EBIT for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$12.9 million.

  • Celularity's EBIT fell 1191.12% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.5 million, marking a year-over-year decrease of 20787.29%. This contributed to the annual value of -$38.4 million for FY2024, which is 8005.17% up from last year.
  • As of Q3 2025, Celularity's EBIT stood at -$12.9 million, which was down 1191.12% from -$15.9 million recorded in Q2 2025.
  • In the past 5 years, Celularity's EBIT ranged from a high of $17.5 million in Q4 2022 and a low of -$99.3 million during Q3 2023
  • For the 5-year period, Celularity's EBIT averaged around -$21.3 million, with its median value being -$11.5 million (2024).
  • The largest annual percentage gain for Celularity's EBIT in the last 5 years was 32675.82% (2021), contrasted with its biggest fall of 2900729.81% (2021).
  • Quarter analysis of 5 years shows Celularity's EBIT stood at -$15.0 million in 2021, then surged by 216.95% to $17.5 million in 2022, then dropped by 23.85% to $13.3 million in 2023, then crashed by 169.7% to -$9.3 million in 2024, then plummeted by 39.01% to -$12.9 million in 2025.
  • Its EBIT stands at -$12.9 million for Q3 2025, versus -$15.9 million for Q2 2025 and -$10.5 million for Q1 2025.